Trial Profile
Study of the B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With Beta-thalassemia Major
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Biomarker; Pharmacodynamics
- 13 May 2013 New trial record